Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Raj Chovatiya, MD, PhD, MSCI, highlights the long-term effectiveness of lebrikizumab across diverse patients, including those with prior biologic use, positioning it as a potential first-line ...

The two approaches developed by our team would provide much-needed relief for patients with diabetic wounds, as well as many patients suffering from skin conditions like atopic dermatitis or psoriasis ...